Stock Valuation — The Compound Family

⚡

Stock Valuation Tool

5 DCF methods · Damodaran WACC · Monte Carlo · Reverse DCF

v2.0 · Damodaran Jan 2026

DCF HistoricalDCF RevenueExit MultipleBuyback-adjustedCapEx Intensity Damodaran WACCMonte Carlo 10KReverse DCF Piotroski F-ScoreAltman Z-ScoreEarnings Quality

Company Ticker

Auto-loads all financial data

Ticker Symbol

Year	Revenue	FCF	FCF Margin	Rev Growth
Load a ticker to see historical data

WACC Calculation

Damodaran method · auto-populated

Beta (market)

Risk-Free Rate (%)

Market Risk Prem (%)

Tax Rate (%)

Sector (Damodaran)

Country (CRP)

Size Premium (%) — enter manually

Large cap: 0% · Mid cap: 1–1.5% · Small cap: 2–3%

📊 Duff & Phelps Size Premium Table — click to expand

Source: Duff & Phelps Cost of Capital Navigator. Added to CAPM cost of equity for smaller companies. Auto-suggested from market cap above.

Market Cap	Size Premium	Examples
Mega Cap (>$50B)	0%	AAPL, MSFT, NVDA, ASML, ANET
Large Cap ($5B–$50B)	0.5–1.0%	Mid-tier tech, industrials
Mid Cap ($1B–$5B)	1.0–1.8%	Regional banks, small SaaS
Small Cap ($300M–$1B)	2.0–3.0%	Small caps, micro SaaS
Micro Cap (<$300M)	3.5–5.0%	Nano cap, penny stocks

⚡ Buttons apply value and recalculate WACC instantly. Premium is automatically suggested when you load a ticker.

Hist. P/E Average

Hist. P/FCF Average

Hist. EV/EBITDA

Terminal Value Method

DCF Forward Model

// PROBABILITY-WEIGHTED FAIR VALUE · 5 METHODS · 25% BEAR / 50% BASE / 25% BULL

$—

vs current price: $—

—

Bear

$—

—

Base

$—

—

Bull

$—

—

Method Breakdown — Base Scenario

Method	Fair Value	Weight	Relative

Sensitivity Analysis

WACC × Revenue Growth Rate

Monte Carlo Simulation

10,000 simulations · Student-t(4) · Cholesky correlations

—

P10 Pessimistic

—

P50 Median

—

P90 Optimistic

—

% Above Market

💾

Save / Load Model

Persist inputs across sessions

↻

Earnings Update Mode

Enter Q results to update fair value

⚠ Enter quarterly revenue. Full-year guidance in $M annual.

Actual Revenue Q ($M)

Analyst Est. Revenue ($M)

Actual EPS ($)

New Full-Year Guidance ($M)

Full-year annual, not quarterly

If you find this tool helpful, support the project

Educational purposes only. Nothing herein constitutes financial advice, investment recommendations, or an offer to buy or sell securities. All valuations depend on assumptions that may prove incorrect. Consult a licensed financial advisor.